These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 1410853)

  • 41. Calcitriol oral therapy for the prevention of secondary hyperparathyroidism in patients with predialytic renal failure.
    Panichi V; Andreini B; De Pietro S; Migliori M; Taccola D; Giovannini L; Ferdeghini M; Palla R
    Clin Nephrol; 1998 Apr; 49(4):245-50. PubMed ID: 9582556
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcemic response to parathyroid hormone in renal failure: role of phosphorus and its effect on calcitriol.
    Rodriguez M; Martin-Malo A; Martinez ME; Torres A; Felsenfeld AJ; Llach F
    Kidney Int; 1991 Dec; 40(6):1055-62. PubMed ID: 1762306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nephrocalcinosis in a dog.
    Rendano VT; Taylor MJ; Robinette JD
    J Am Vet Med Assoc; 1976 Aug; 169(3):319-21. PubMed ID: 956017
    [No Abstract]   [Full Text] [Related]  

  • 44. Effect of intravenous calcitriol on platelet intracellular calcium in uremic hemodialysis patients with secondary hyperparathyroidism.
    Lin SH; Shieh SD; Chyr SH; Lu KC; Lin YF; Diang LK; Chou TC; Ding YA
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):240-5. PubMed ID: 7982134
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pathophysiology and treatment of secondary hyperparathyroidism in patients with chronic renal failure.
    Tsukamoto Y
    Nephrol Dial Transplant; 1995; 10 Suppl 3():22-4. PubMed ID: 7494609
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Safety and efficacy of long-term treatment of secondary hyperparathyroidism by low-dose intravenous calcitriol.
    Sprague SM; Moe SM
    Am J Kidney Dis; 1992 Jun; 19(6):532-9. PubMed ID: 1595701
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Survival of cats with naturally occurring chronic renal failure: effect of dietary management.
    Elliott J; Rawlings JM; Markwell PJ; Barber PJ
    J Small Anim Pract; 2000 Jun; 41(6):235-42. PubMed ID: 10879400
    [TBL] [Abstract][Full Text] [Related]  

  • 48. PTH secretion in patients with chronic renal failure assessed by a modified CiCa clamp method: effects of 1-year calcitriol therapy.
    Schindler S; Mannstadt M; Urena P; Segre GV; Stein G
    Clin Nephrol; 2004 Apr; 61(4):253-60. PubMed ID: 15125031
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Chronic renal failure in the dog and cat.
    English PB
    Aust Vet J; 1973 Feb; 49(2):74-80. PubMed ID: 4120968
    [No Abstract]   [Full Text] [Related]  

  • 50. Percutaneous ultrasound-guided chemical parathyroid ablation for treatment of primary hyperparathyroidism in dogs.
    Long CD; Goldstein RE; Hornof WJ; Feldman EC; Nyland TG
    J Am Vet Med Assoc; 1999 Jul; 215(2):217-21. PubMed ID: 10416475
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D3 in patients on maintenance haemodialysis.
    Rassoul Z; Mousa D; Rehman MA; Abdalla AH; Hawas F; Popovich W; Gaisoum M; al-Sulaiman M; Al-Khader A
    Am J Nephrol; 1995; 15(6):507-11. PubMed ID: 8546173
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy.
    Goodman WG; Ramirez JA; Belin TR; Chon Y; Gales B; Segre GV; Salusky IB
    Kidney Int; 1994 Oct; 46(4):1160-6. PubMed ID: 7861712
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hyperparathyroidism and 1,25-dihydroxyvitamin D deficiency in mild, moderate, and severe renal failure.
    Pitts TO; Piraino BH; Mitro R; Chen TC; Segre GV; Greenberg A; Puschett JB
    J Clin Endocrinol Metab; 1988 Nov; 67(5):876-81. PubMed ID: 3182962
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Are we mismanaging calcium and phosphate metabolism in renal failure?
    Hsu CH
    Am J Kidney Dis; 1997 Apr; 29(4):641-9. PubMed ID: 9100059
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 'Pulse oral' versus intravenous calcitriol therapy in chronic hemodialysis patients. A prospective and randomized study.
    Bacchini G; Fabrizi F; Pontoriero G; Marcelli D; Di Filippo S; Locatelli F
    Nephron; 1997; 77(3):267-72. PubMed ID: 9375818
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hypocalcemia may not be essential for the development of secondary hyperparathyroidism in chronic renal failure.
    Lopez-Hilker S; Galceran T; Chan YL; Rapp N; Martin KJ; Slatopolsky E
    J Clin Invest; 1986 Oct; 78(4):1097-102. PubMed ID: 3760186
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Management of secondary hyperparathyroidism: the gap between diagnosis and treatment. The Renal Osteodystrophy Multicenter Enquiry.
    Díaz-Corte C; Cannata-Andía JB
    Am J Med Sci; 2000 Aug; 320(2):107-11. PubMed ID: 10981485
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of paricalcitol on mineral bone metabolism in kidney transplant recipients with secondary hyperparathyroidism.
    Borrego Utiel FJ; Bravo Soto JA; Merino Pérez MJ; González Carmelo I; López Jiménez V; García Álvarez T; Acosta Martínez Y; Mazuecos Blanca MA
    Nefrologia; 2015; 35(4):363-73. PubMed ID: 26306956
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of calcitriol treatment and withdrawal on hyperparathyroidism in haemodialysis patients with hypocalcaemia.
    Jara A; Chacón C; Valdivieso A; Aris L; Jalil R; Felsenfeld AJ
    Nephrol Dial Transplant; 2001 May; 16(5):1009-16. PubMed ID: 11328908
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hypocalcemia of critical illness in dogs and cats.
    Holowaychuk MK
    Vet Clin North Am Small Anim Pract; 2013 Nov; 43(6):1299-317, vi-vii. PubMed ID: 24144092
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.